1. PMO-176 Induction maintenance treatment in chronic hepatitis B; step-down from tenofovir and lamivudine to lamivudine monotherapy is effective. (28th May 2012) Authors: Gill, U S; Payaniandy, L; Payaniandy, D; Schulz, J; Ross, V; Kallis, Y; Kooner, P; Marley, R; Kennedy, P T F; Foster, G R Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTU-117 Sequential NUC therapy following pegylated interferon provides a greater decline in HBSAG and potentially offers a treatment advantage over current therapies. (22nd June 2015) Authors: Gill, US; Hansi, NK; Payaniandy, L; Schulz, J; Payaniandy, D; Alazawi, W; Dearden, J; Kallis, YN; Kooner, P; Marley, R; Tong, W; Foster, GR; Kennedy, PTF Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-143 Sequential Oral Anti-Viral Therapy Following Pegylated-Interferon-Alpha Failure Significantly Increases Hbsag Decline. (4th June 2013) Authors: Gill, U S; Payaniandy, L; Schulz, J; Payaniandy, D; Ross, V; Kallis, Y; Kooner, P; Marley, R; Foster, G R; Kennedy, P T Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗